-
Bum Ju Ahn,
Hoang Le,
Min Wook Shin,
Sung-Jin Bae,
Eun Ji Lee,
Hee-Jun Wee,
Jong Ho Cha, Ji-Hyeon Park,
Hye Shin Lee,
Hyo-Jong Lee,
Hyunsook Jung,
Zee-Yong Park,
Sang Ho Park,
Byung Woo Han,
Ji Hae Seo,
Eng H Lo,
Kyu-Won Kim
[show abstract]
[hide abstract]
ABSTRACT: Ninjurin1 is known as an adhesion molecule promoting leukocyte trafficking under inflammatory conditions. However, the posttranslational modifications of Ninjurin1 are poorly understood. Herein, we defined the proteolytic cleavage of Ninjurin1 and its functions. HEK293T cells overexpressing the C- or N-terminus tagging mouse Ninjurin1 plasmid produced additional cleaved forms of Ninjurin1 in the lysates or conditioned media (CM). Two custom-made anti-Ninjurin1 antibodies, Ab(1-15) or Ab(139-152), specific to the N- or C-terminal regions of Ninjurin1 revealed the presence of its shedding fragments in the mouse liver and kidney lysates. Furthermore, Matrix Metalloproteinase (MMP) 9 was responsible for Ninjurin1 cleavage between Leu(56) and Leu(57). Interestingly, the soluble N-terminal Ninjurin1 fragment has structural similarity with well-known chemokines. Indeed, the CM from HEK293T cells overexpressing the GFP-mNinj1 plasmid was able to attract Raw264.7 cells in trans-well assay. Collectively, we suggest that the N-terminal ectodomain of mouse Ninjurin1, which may act as a chemoattractant, is cleaved by MMP9.
Biochemical and Biophysical Research Communications 11/2012; · 2.48 Impact Factor
-
Wolfram Hoetzenecker,
Bernd Echtenacher,
Emmanuella Guenova,
Konrad Hoetzenecker,
Florian Woelbing,
Jürgen Brück,
Anna Teske,
Nadejda Valtcheva,
Kerstin Fuchs,
Manfred Kneilling, Ji-Hyeon Park,
Kyu-Han Kim,
Kyu-Won Kim,
Petra Hoffmann,
Claus Krenn,
Tsonwin Hai,
Kamran Ghoreschi,
Tilo Biedermann,
Martin Röcken
[show abstract]
[hide abstract]
ABSTRACT: Sepsis, sepsis-induced hyperinflammation and subsequent sepsis-associated immunosuppression (SAIS) are important causes of death. Here we show in humans that the loss of the major reactive oxygen species (ROS) scavenger, glutathione (GSH), during SAIS directly correlates with an increase in the expression of activating transcription factor 3 (ATF3). In endotoxin-stimulated monocytes, ROS stress strongly superinduced NF-E2-related factor 2 (NRF2)-dependent ATF3. In vivo, this ROS-mediated superinduction of ATF3 protected against endotoxic shock by inhibiting innate cytokines, as Atf3(-/-) mice remained susceptible to endotoxic shock even under conditions of ROS stress. Although it protected against endotoxic shock, this ROS-mediated superinduction of ATF3 caused high susceptibility to bacterial and fungal infections through the suppression of interleukin 6 (IL-6). As a result, Atf3(-/-) mice were protected against bacterial and fungal infections, even under conditions of ROS stress, whereas Atf3(-/-)Il6(-/-) mice were highly susceptible to these infections. Moreover, in a model of SAIS, secondary infections caused considerably less mortality in Atf3(-/-) mice than in wild-type mice, indicating that ROS-induced ATF3 crucially determines susceptibility to secondary infections during SAIS.
Nature medicine 12/2011; 18(1):128-34. · 27.14 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A two dimensionally assembled monolayer of hexagonal convexo-convex β-cobalt hydroxide nanoplates as a self-disposable sacrificial epi-template leads to a highly vertical alignment of zinc oxide nanorods array having a good electrical contact with metal or semiconductor layer on a substrate in a hydrothermal process.
Chemical Communications 11/2011; 47(48):12819-21. · 6.17 Impact Factor
-
Ji Hae Seo,
Jong-Ho Cha, Ji-Hyeon Park,
Chul-Ho Jeong,
Zee-Yong Park,
Hye-Suk Lee,
Seung Hyun Oh,
Ju-Hee Kang,
Se Won Suh,
Kyoung Hoon Kim, [......],
Jeong Ae Park,
Joo-Won Jeong,
Kong-Joo Lee,
Goo Taeg Oh,
Mi-Ni Lee,
Sung Won Kwon,
Seung-Ki Lee,
Kwang-Hoon Chun,
Su-Jae Lee,
Kyu-Won Kim
[show abstract]
[hide abstract]
ABSTRACT: The N-acetyltransferase arrest defective 1 (ARD1) is an important regulator of cell growth and differentiation that has emerged recently as a critical molecule in cancer progression. However, the regulation of the enzymatic and biological activities of human ARD1 (hARD1) in cancer is presently poorly understood. Here, we report that hARD1 undergoes autoacetylation and that this modification is essential for its functional activation. Using liquid chromatography-tandem mass spectrometry and site-directed mutational analyses, we identified K136 residue as an autoacetylation target site. K136R mutation abolished the ability of hARD1 to promote cancer cell growth in vitro and tumor xenograft growth in vivo. Mechanistic investigations revealed that hARD1 autoacetylation stimulated cyclin D1 expression through activation of the transcription factors beta-catenin and activator protein-1. Our results show that hARD1 autoacetylation is critical for its activation and its ability to stimulate cancer cell proliferation and tumorigenesis.
Cancer Research 06/2010; 70(11):4422-32. · 7.86 Impact Factor
-
Mi-Ni Lee,
Shi-Nai Lee,
Se-Hee Kim,
Bora Kim,
Bo-Kyung Jung,
Ji Hae Seo, Ji-Hyeon Park,
Jae-Hoon Choi,
Sun Hee Yim,
Mi-Ran Lee,
Jong-Gil Park,
Ji-Young Yoo,
Jeong Hun Kim,
Seung-Taek Lee,
Hwan-Mook Kim,
Sandra Ryeom,
Kyu-Won Kim,
Goo Taeg Oh
[show abstract]
[hide abstract]
ABSTRACT: Vascular endothelial growth factor A (VEGFA), a critical mediator of tumor angiogenesis, is a well-characterized target of hypoxia-inducible factor 1 (HIF-1). Murine arrest-defective protein 1A (mARD1A(225)) acetylates HIF-1alpha, triggering its degradation, and thus may play a role in decreased expression of VEGFA.
We generated Apc(Min/+)/mARD1A(225) transgenic mice and quantified growth of intestinal polyps. Human gastric MKN74 and murine melanoma B16F10 cells overexpressing mARD1A(225) were injected into mice, and tumor growth and metastasis were measured. VEGFA expression and microvessel density in tumors were assessed using immunohistochemistry. To evaluate the role of mARD1A(225) acetylation of Lys532 in HIF-1alpha, we injected B16F10-mARD1A(225) cell lines stably expressing mutant HIF-1alpha/K532R into mice and measured metastasis. All statistical tests were two-sided, and P values less than .05 were considered statistically significant.
Apc(Min/+)/mARD1A(225) transgenic mice (n = 25) had statistically significantly fewer intestinal polyps than Apc(Min/+) mice (n = 21) (number of intestinal polyps per mouse: Apc(Min/+) mice vs Apc(Min/+)/mARD1A(225) transgenic mice, mean = 83.4 vs 38.0 polyps, difference = 45.4 polyps, 95% confidence interval [CI] = 41.8 to 48.6; P < .001). The growth and metastases of transplanted tumors were also statistically significantly reduced in mice injected with mARD1A(225)-overexpressing cells than in mice injected with control cells (P < .01). Moreover, overexpression of mARD1A(225) decreased VEGFA expression and microvessel density in tumor xenografts (P < .04) and Apc(Min/+) intestinal polyps (P = .001). Mutation of lysine 532 of HIF-1alpha in B16F10-mARD1A(225) cells prevented HIF-1alpha degradation and inhibited the antimetastatic effect of mARD1A(225) (P < .001).
mARD1A(225) may be a novel upstream target that blocks VEGFA expression and tumor-related angiogenesis.
CancerSpectrum Knowledge Environment 03/2010; 102(6):426-42. · 14.07 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: While conventional G-banded karyotyping still remains a gold standard in prenatal genetic diagnoses, the widespread adoption of array Comparative Genomic Hybridization (array CGH) technology for postnatal genetic diagnoses has led to increasing interest in the use of this same technology for prenatal diagnosis. We have investigated the value of our own designed DNA chip as a prenatal diagnostic tool for detecting submicroscopic deletions/duplications and chromosome aneuploidies.
We designed a target bacterial artificial chromosome (BAC)-based aCGH platform (MacArray M-chip), which specifically targets submicroscopic deletions/duplications for 26 known genetic syndromes of medical significance observed prenatally. To validate the DNA chip, we obtained genomic DNA from 132 reference materials generated from patients with 22 genetic diseases and 94 clinical amniocentesis samples obtained for karyotyping.
In the 132 reference materials, all known genomic alterations were successfully identified. In the 94 clinical samples that were also subjected to conventional karyotyping, three cases of balanced chromosomal aberrations were not detected by aCGH. However, we identified eight cases of microdeletions in the Yq11.23 chromosomal region that were not found by conventional karyotyping. This region harbors the DAZ gene, and deletions may lead to non-obstructive spermatogenesis.
We have successfully designed and applied a BAC-based aCGH platform for prenatal diagnosis. This platform can be used in conjunction with conventional karyotyping and will provide rapid and accurate diagnoses for the targeted genomic regions while eliminating the need to interpret clinically-uncertain genomic regions.
BMC Medical Genetics 01/2010; 11:102. · 2.33 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Bacterial phosphopantetheine adenylyltransferase (PPAT) catalyzes the penultimate step in the coenzyme A (CoA) biosynthetic pathway. It catalyzes the reversible transfer of an adenylyl group from ATP to 4'-phosphopantetheine (Ppant) to form dephospho-CoA (dPCoA) and pyrophosphate. Previous structural studies have revealed how several ligands are recognized by bacterial PPATs. ATP, ADP, Ppant and dPCoA bind to the same binding site in a highly similar manner, while CoA binds to a partially overlapping site in a different mode. To provide further structural insights into ligand binding, the crystal structure of Staphylococcus aureus PPAT was solved in a binary complex with 3'-phosphoadenosine 5'-phosphosulfate (PAPS). This study unexpectedly revealed a new mode of ligand binding to PPAT, thus providing potentially useful information for structure-based discovery of inhibitors of bacterial PPATs.
Acta Crystallographica Section F Structural Biology and Crystallization Communications 10/2009; 65(Pt 10):987-91. · 0.51 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To estimate the combined screening performance of first and early second trimester prenatal serum markers for Down syndrome, in screening for the development of preeclampsia, and analyze the correlation among marker levels, week of onset, and severity of the disease.
A retrospective cohort study was carried out on 32 women with preeclampsia and 3044 controls. Serum samples from these pregnancies were assayed for pregnancy-associated plasma protein-A (PAPP-A), alpha-fetoprotein (AFP), unconjugated estriol (uE3), human chorionic gonadotrophin (hCG), and inhibin-A. A likelihood ratio and the odds of being affected given a positive result (OAPR) of various combinations of markers were calculated and receiver operating characteristic (ROC) curves analysis was performed.
In the pregnancies that subsequently developed preeclampsia, first trimester PAPP-A concentration was significantly lower and concentrations of early second trimester inhibin-A and hCG significantly elevated. Levels of early second trimester uE3 and AFP were not significantly altered. We also found that inhibin-A correlates with both onset of the disease and the severity.
Down syndrome biochemical markers levels are altered in those patients who subsequently developed preeclampsia and may be a useful screening test for preeclampsia. Inhibin-A is the most predictive marker and correlates with the severity of subsequent preeclampsia and inversely with the week of occurrence of preeclampsia.
Prenatal Diagnosis 08/2008; 28(8):704-9. · 2.11 Impact Factor
